California-based technologist and author Rajeev Nanda invites readers on a gripping intellectual and emotional journey with his latest book, “LOH,” which has achieved Amazon Bestseller status as #8 in ...
Biogen has won U.S. Food and Drug Administration breakthrough-therapy designation for its litifilimab drug candidate for the treatment of the chronic autoimmune disease cutaneous lupus erythematosus, ...
– Breakthrough Therapy Designation granted to NXC-201 based on positive NEXICART-2 Phase 2 interim clinical results, presented at the American Society of Hematology (ASH) 2025 annual meeting – – Final ...
Litifilimab significantly improved skin disease activity in CLE, with a CLASI-A score difference from placebo of up to -33.4 percentage points. The Food and Drug Administration (FDA) has granted ...
Please provide your email address to receive an email when new articles are posted on . Ianalumab has received the FDA’s breakthrough therapy designation for Sjögren’s disease. Novartis plans to ...
Hosted on MSN
What this breakthrough means for nuclear fusion
In this video, we explore the recent announcement of net positive energy gain using lasers for nuclear fusion ignition. We delve into how lasers and Inertial Confinement Fusion (ICF) operate and ...
Scientists at Stanford Medicine have discovered a treatment that can reverse cartilage loss in aging joints and even prevent arthritis after knee injuries. By blocking a protein linked to aging, the ...
INDIANAPOLIS, Jan. 20, 2026 /PRNewswire/ -- Eli Lilly and Company (LLY) today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to sofetabart ...
Regulatory submission for ianalumab in Sjögren disease is expected in early 2026, according to Novartis. The Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results